| 参考文献: |
1. Schuhmann-Giampieri G, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992 Apr;183(1):59-64. 2. Katsube T, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011 Apr;46(4):277-83. 3. Saito K, et al. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci. 2005;4(1):1-9. 4. Chernyak V, et al. Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI-RADS)[J]. J Magn Reson Imaging. 2019 May;49(5):1236-1252. 5. Huh J, et al. Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver[J]. Korean J Radiol. 2015 Nov-Dec;16(6):1207-15. 6. Wei P, et al. Gadolinium deposition in the liver and brain in a rat model with liver fibrosis after intravenous administration of gadoxetate disodium[J]. Heliyon. 2024 Mar 8;10(6):e27419. |